KRRO vs REGN: Which Stock is Better?
Side-by-side comparison of Korro Bio Inc and Regeneron Pharmaceuticals Inc in 2026
KRRO
Korro Bio Inc
$13.69
REGN
Regeneron Pharmaceuticals Inc
$755.51
Key Metrics Comparison
| Metric | KRRO | REGN | Winner |
|---|---|---|---|
| Market Cap | $182.88M | $78.92B | REGN |
| P/E Ratio | N/A | 17.99 | REGN |
| EPS (TTM) | $N/A | $41.50 | REGN |
| Revenue Growth | -0.4% | 0.0% | REGN |
| Gross Margin | -762.5% | 44.6% | REGN |
Analyze KRRO
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KRRO or REGN a better investment?
Comparing KRRO and REGN: Korro Bio Inc has a market cap of $182.88M while Regeneron Pharmaceuticals Inc has $78.92B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KRRO and REGN?
KRRO (Korro Bio Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KRRO or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: KRRO or REGN?
REGN has higher revenue growth at 0.0% vs -0.4% for KRRO.
Which company is more profitable: KRRO or REGN?
Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to -762.5% for KRRO.
Which is the larger company: KRRO or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $78.92B compared to $182.88M for KRRO.
Should I buy KRRO or REGN in 2026?
Both KRRO and REGN have investment merit. KRRO trades at $13.69 while REGN trades at $755.51. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KRRO and REGN stock?
Key differences: Market Cap ($182.88M vs $78.92B), P/E Ratio (N/A vs 18.0x), Revenue Growth (-0.4% vs 0.0%), Gross Margin (-762.5% vs 44.6%).